5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.82▼ | 1.82▼ | 1.82▼ | 1.82▼ | 1.95▼ |
MA10 | 1.84▼ | 1.85▼ | 1.85▼ | 1.90▼ | 2.11▼ |
MA20 | 1.90▼ | 1.91▼ | 1.93▼ | 2.02▼ | 2.18▼ |
MA50 | 2.01▼ | 1.98▼ | 2.03▼ | 2.14▼ | 2.09▼ |
MA100 | 1.99▼ | 2.07▼ | 2.08▼ | 2.19▼ | 6.23▼ |
MA200 | 2.07▼ | 2.09▼ | 2.20▼ | 1.98▼ | 22.18▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | -0.011▼ | -0.012▼ | -0.030▼ | -0.007▼ |
RSI | 27.359▼ | 29.854▼ | 32.681▼ | 40.833▼ | 42.878▼ |
STOCH | 21.185 | 20.483 | 18.878▼ | 13.525▼ | 24.617 |
WILL %R | -94.118▼ | -94.118▼ | -95.833▼ | -90.801▼ | -93.663▼ |
CCI | -123.434▼ | -124.950▼ | -121.622▼ | -104.418▼ | -132.039▼ |
▲ GAP | $NLSP Open Gap Up %2 | Set Alert |
Tuesday, September 30, 2025 08:53 AM
Under the approved terms, Kadimastem shareholders will own 84.4% of the combined company, while NLS shareholders will retain just 15.6% ownership. This exchange ratio reflects the relative value ...
|
Tuesday, September 30, 2025 04:48 AM
An update from NLS Pharmaceutics ( ($NLSP) ) is now available. On September 30, 2025, NLS Pharmaceutics announced that its shareholders approved a ...
|
Tuesday, September 30, 2025 04:14 AM
NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system ("CNS") disorders, and Kadimastem Ltd. (TASE: KDST) ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/10/25 | 1.81 | 1.8516 | 1.7001 | 1.77 | 81,057 |
10/10/25 | 1.84 | 1.8595 | 1.75 | 1.76 | 173,196 |
09/10/25 | 1.86 | 1.9067 | 1.83 | 1.87 | 56,977 |
08/10/25 | 1.83 | 1.873 | 1.82 | 1.865 | 115,066 |
07/10/25 | 1.90 | 1.93 | 1.81 | 1.83 | 168,489 |
06/10/25 | 1.96 | 1.98 | 1.8601 | 1.92 | 169,939 |
03/10/25 | 2.13 | 2.13 | 1.97 | 1.995 | 245,707 |
02/10/25 | 2.05 | 2.15 | 1.98 | 2.12 | 286,229 |
01/10/25 | 1.79 | 2.09 | 1.76 | 2.07 | 699,934 |
30/09/25 | 2.215 | 2.24 | 1.76 | 1.83 | 12,827,525 |
|
|
||||
|
|
||||
|
|